VanEck Associates’s Steris STE Stock Holding History

VanEck Associates’s Portfolio STE Stock Details STE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-16,481	Closed	-$4.08M	–	1492
2025 Q3	$4.08M	Buy	16,481 +1,449	+10%	+$347K	﹤0.01%	831
2025 Q2	$3.61M	Sell	15,032 -14,841	-50%	-$3.46M	﹤0.01%	837
2025 Q1	$6.77M	Buy	29,873 +1,057	+4%	+$232K	0.01%	601
2024 Q4	$5.92M	Buy	28,816 +16,300	+130%	+$3.58M	0.01%	625
2024 Q3	$2.77M	Sell	12,516 -1,299	-9%	-$304K	﹤0.01%	844
2024 Q2	$3.03M	Sell	13,815 -656	-5%	-$143K	﹤0.01%	759
2024 Q1	$3.25M	Buy	14,471 +2,065	+17%	+$466K	﹤0.01%	720
2023 Q4	$2.73M	Buy	12,406 +364	+3%	+$77K	0.01%	718
2023 Q3	$2.64M	Buy	12,042 +1,424	+13%	+$322K	0.01%	677
2023 Q2	$2.39M	Sell	10,618 -1,015	-9%	-$203K	0.01%	682
2023 Q1	$2.23M	Sell	11,633 -1,077	-8%	-$208K	0.01%	688
2022 Q4	$2.35M	Sell	12,710 -460	-3%	-$80.9K	0.01%	645
2022 Q3	$2.19M	Buy	13,170 +1,909	+17%	+$388K	0.01%	626
2022 Q2	$2.32M	Buy	11,261 +474	+4%	+$107K	0.01%	627
2022 Q1	$2.61M	Buy	10,787 +724	+7%	+$168K	0.01%	651
2021 Q4	$2.45M	Buy	10,063 +220	+2%	+$50.3K	0.01%	660
2021 Q3	$2.01M	Sell	9,843 -4,670	-32%	-$999K	0.01%	684
2021 Q2	$2.99M	Buy	14,513 +2,610	+22%	+$525K	0.01%	563
2021 Q1	$2.27M	Buy	11,903 +1,186	+11%	+$220K	0.01%	582
2020 Q4	$2.03M	Buy	10,717 +2,569	+32%	+$479K	0.01%	541
2020 Q3	$1.44M	Sell	8,148 -12,930	-61%	-$2.07M	﹤0.01%	556
2020 Q2	$3.23M	Buy	21,078 +27	+0.1%	+$4.11K	0.01%	403
2020 Q1	$2.95M	Sell	21,051 -3,588	-15%	-$537K	0.02%	395
2019 Q4	$3.75M	Sell	24,639 -442	-2%	-$64.8K	0.01%	410
2019 Q3	$3.62M	Buy	25,081 +497	+2%	+$74.3K	0.02%	391
2019 Q2	$3.66M	Buy	24,584 +1,659	+7%	+$222K	0.02%	384
2019 Q1	$2.94M	Buy	22,925 +3,253	+17%	+$383K	0.01%	409
2018 Q4	$2.1M	Sell	19,672 -1,736	-8%	-$194K	0.01%	431
2018 Q3	$2.45M	Buy	21,408 +172	+0.8%	+$19.4K	0.01%	444
2018 Q2	$2.23M	Sell	21,236 -1,914	-8%	-$193K	0.01%	453
2018 Q1	$2.16M	Buy	23,150 +4,017	+21%	+$365K	0.01%	387
2017 Q4	$1.67M	Sell	19,133 -239	-1%	-$21.3K	0.01%	415
2017 Q3	$1.71M	Sell	19,372 -4,470	-19%	-$379K	0.01%	418
2017 Q2	$1.94M	Buy	23,842 +13,072	+121%	+$994K	0.01%	405
2017 Q1	$748K	Buy	10,770 +45	+0.4%	+$3.11K	﹤0.01%	539
2016 Q4	$723K	Buy	10,725 +1,658	+18%	+$112K	﹤0.01%	523
2016 Q3	$663K	Sell	9,067 -1,365	-13%	-$96.4K	﹤0.01%	542
2016 Q2	$717K	Buy	10,432 +1,532	+17%	+$107K	﹤0.01%	503
2016 Q1	$632K	Buy	8,900 +1,180	+15%	+$79.8K	﹤0.01%	501
2015 Q4	$582K	Sell	7,720 -650	-8%	-$47K	﹤0.01%	450
2015 Q3	$544K	Sell	8,370 -568	-6%	-$37.5K	﹤0.01%	458
2015 Q2	$576K	Buy	8,938 +594	+7%	+$40.1K	﹤0.01%	473
2015 Q1	$586K	Buy	8,344 +1,104	+15%	+$72.8K	﹤0.01%	472
2014 Q4	$470K	Sell	7,240 -971	-12%	-$60K	﹤0.01%	496
2014 Q3	$443K	Sell	8,211 -1,590	-16%	-$86.4K	﹤0.01%	514
2014 Q2	$524K	Sell	9,801 -449	-4%	-$23.1K	﹤0.01%	486
2014 Q1	$489K	Buy	10,250 +100	+1%	+$4.68K	﹤0.01%	465
2013 Q4	$488K	Buy	+10,150	New	+$464K	﹤0.01%	452

Other funds holding STE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VanEck Associates's STE Position: Q4 2025 in Review

VanEck Associates sold out of Steris (STE) in Q4 2025, closing a stake of 16,481 shares — an estimated $4.08M sold.

VanEck Associates first reported a position in STE in Q4 2013 and held it in 48 quarters. The position peaked at $6.77M in Q1 2025. 897 funds tracked by Wall St. Rank hold STE as of Q4 2025.

VanEck Associates reported no remaining Steris position as of Q4 2025 after selling out during the quarter.
VanEck Associates sold 16,481 Steris shares in Q4 2025, an estimated $4.08M.
VanEck Associates first reported a position in Steris in Q4 2013 and held it in 48 quarters.
VanEck Associates's Steris position peaked at $6.77M in Q1 2025.
897 funds tracked by Wall St. Rank held Steris as of Q4 2025.

Based on VanEck Associates's 13F filing for Q4 2025, filed 13 Feb 2026.